Cargando…
Neuromuscular Junction Protection for the Potential Treatment of Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a neuromuscular disease characterized by the progressive degeneration of upper and lower motor neurons (MNs), leading to muscular atrophy and eventual respiratory failure. ALS research has primarily focused on mechanisms regarding MN cell death; however, degene...
Autores principales: | Krakora, Dan, Macrander, Corey, Suzuki, Masatoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423938/ https://www.ncbi.nlm.nih.gov/pubmed/22919482 http://dx.doi.org/10.1155/2012/379657 |
Ejemplares similares
-
Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis
por: Cappello, Valentina, et al.
Publicado: (2017) -
TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis
por: Lépine, Sarah, et al.
Publicado: (2022) -
Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS)
por: Alhindi, Abrar, et al.
Publicado: (2021) -
The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis
por: Pollari, Eveliina, et al.
Publicado: (2014) -
Adducin at the Neuromuscular Junction in Amyotrophic Lateral Sclerosis: Hanging on for Dear Life
por: Krieger, Charles, et al.
Publicado: (2016)